Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial-Reference-Cited by-同舟云学术

Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial

Published:2014-10-02 Issue:1 Volume:33 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Thomaidis Thomas,Maderer Annett,Formentini Andrea,Bauer Susanne,Trautmann Mario,Schwarz Michael,Neumann Wiebke,Kittner Jens Martin,Schad Arno,Link Karl-Heinrich,Rey Johannes Wilhelm,Weinmann Arndt,Hoffman Arthur,Galle Peter Robert,Kornmann Marko,Moehler Markus

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-014-0083-8.pdf

Reference61 articles.

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.

2. Golan T, Urban D, Berger R, Lawrence YR: Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location. Cancer. 2013, 119 (16): 3084-3091. 10.1002/cncr.28143.

3. Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009, 27 (19): 3109-3116. 10.1200/JCO.2008.20.6771.

4. Cao Y: Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal. 2009, 2 (59): re1-10.1126/scisignal.259re1.

5. Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM: Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer. 2012, 12: 47-10.1186/1471-2407-12-47.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Novel Prognostic Panel for Colorectal Cancer Based on Cancer Functional Status, and Validation of STC2 as a Promising Biomarker;Frontiers in Bioscience-Landmark;2024-07-02

2. Precision Oncology: Circulating Microvesicles as New Biomarkers in a Very Early Stage of Colorectal Cancer;Cancers;2024-05-20

3. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer;eLife;2022-10-25

4. Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden;Journal of Gastrointestinal Oncology;2022-10

5. Patient-centered developments in colon- and rectal cancer with a multidisciplinary international team: From translational research to national guidelines;World Journal of Gastrointestinal Surgery;2021-12-27